
News|Articles|November 5, 2025
A Strategic Assessment Tool for Modernizing Buffer Preparation in Biologics Facilities
Key Takeaways
- Bioproduction buffer preparation is shifting towards integrating advanced technologies for improved efficiency.
- Facilities are adopting a mix of traditional and innovative buffer strategies, such as in-line dilution.
A paradigm shift in bioproduction buffer preparation is on the horizon. While some facilities maintain made-in-house operations, some leverage a combination of different buffer strategies and technologies, like in-line dilution, to optimize their efficiency. A multi-criteria assessment framework is introduced here, allowing users to evaluate the mix of buffer strategies based on multiple criteria, which can be prioritized and weighted according to their organizational preferences.
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5


